Cellectis (CLLS) Return on Invested Capital [ROIC] (2022 - 2026)
Cellectis (CLLS) posted Return on Invested Capital [ROIC] of -44.70% for Q2 2026, down 16.46 percentage points from -28.24% a year earlier and down 12.93 percentage points from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Return on Invested Capital [ROIC] (2022 - 2026) Analysis & Trends
For FY2025, Cellectis' Return on Invested Capital [ROIC] came in at -19.94%.
- Annual Return on Invested Capital [ROIC] shows a three-year change of +24.53 percentage points (FY2022 to FY2025).
- In prior years, Cellectis' Return on Invested Capital [ROIC] was -66.80% in FY2023 (-22.34 pp) and -44.46% in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Return on Invested Capital [ROIC] since Q1 2024.
- On a year-over-year basis, Return on Invested Capital [ROIC] increased in five of the last seven quarters, with an average year-over-year change of +15.66 percentage points.
- The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was Q4 2024, with a gain of 50.76 percentage points; the weakest was Q2 2026, with a drop of 16.46 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Cellectis | 143.49 Mn | -609.91 Mn | - | -44.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.70% |
| Mar 31, 2026 | -31.78% |
| Dec 31, 2025 | -21.08% |
| Jun 30, 2025 | -28.24% |
| Mar 31, 2025 | -28.85% |
| Dec 31, 2024 | -23.15% |
| Sep 30, 2024 | -26.46% |
| Jun 30, 2024 | -38.63% |
| Mar 31, 2024 | -63.79% |
| Dec 31, 2023 | -73.91% |
| Sep 30, 2023 | -57.29% |
| Jun 30, 2023 | -57.82% |
| Mar 31, 2023 | -58.37% |
| Dec 31, 2022 | -58.28% |
API Access
Cellectis Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();